Comparing Ultrathin and Thin-Strut Stents in HBR PCI



Ultrathin-strut stents are less thrombogenic than thicker ones, reducing platelet activation and target lesion failure. However, data on their use in high bleeding risk (HBR) patients with short dual antiplatelet therapy (DAPT) regimens is lacking.

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our